Loading clinical trials...

Gene Therapy for Achromatopsia (CNGB3) | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 1/2NCT03001310

Gene Therapy for Achromatopsia (CNGB3)

A clinical trial of AAV - CNGB3 retinal gene therapy for patients with achromatopsia

Lead sponsor: MeiraGTx UK II Ltd•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Related studies

Active Not RecruitingPhase 1/2

Safety and Efficacy of rAAV.hCNGA3 Gene Therapy in Patients With CNGA3-linked Achromatopsia

NCT02610582 · Achromatopsia

TERMINATED

Long-Term Follow-Up Gene Therapy Study for Achromatopsia CNGB3 and CNGA3

NCT03278873 · Achromatopsia

COMPLETEDPhase 1/2

Gene Therapy for Achromatopsia (CNGA3)

NCT03758404 · Achromatopsia

COMPLETED

Clinical and Genetic Characterization of Individuals With Achromatopsia

NCT01846052 · Achromatopsia

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 8, 2023Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE1/PHASE2

Enrollment23

Start dateJan 2017

Last updatedMar 8, 2023

Condition

Achromatopsia

Locations shown

University of Michigan Kellog Eye Centre

Ann Arbor, Michigan

Moorfields Eye Hospital NHS Foundation Trust

London

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 8, 2023Data synced to Clareo: April 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions